NCT00623142View on ClinicalTrials.gov

The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2008

Conditions
Myocardial Reperfusion InjuryCytoprotection
Interventions
DRUG

Hyperbaric Oxygen

100% Oxygen at 2.4 ATA for 30 minutes followed by 5 minutes break followed by 100% Oxygen at 2.4 ATA for another 30 minutes. This intervention was given about 4 to 5 hours prior to CABG

Trial Locations (1)

HU16 5JQ

Hull & East Yorkshire NHS Trust (Castle Hill Hospital), Hull

All Listed Sponsors
collaborator

North of England Medical & Hyperbaric Services

UNKNOWN

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT00623142 - The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery | Biotech Hunter | Biotech Hunter